European Patent Office

T 0663/02 vom 17.03.2011

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2011:T066302.20110317
Datum der Entscheidung
17. März 2011
Aktenzeichen
T 0663/02
Antrag auf Überprüfung von
-
Anmeldenummer
96944505.5
IPC-Klasse
G01R 33/563
Verfahrenssprache
Englisch
Verteilung
An die Kammervorsitzenden und -mitglieder verteilt (B)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
Method for magnetic resonance imaging of arteries using a magnetic resonance contrast agent
Name des Antragstellers
Prince, Martin, R.
Name des Einsprechenden
Koninklijke Philips Electronics N.V.
Kammer
3.4.01
Leitsatz

I. The fact that an intravenous injection of a magnetic resonance contrast agent can be delegated by a physician to a qualified paramedical professional indicates that such an injection may be considered as representing a minor routine intervention which does not imply a substantial health risk when carried out with the required care and skill. Such acts would be ruled out from the scope of the application of the exclusion clause pursuant to Article 53(c) EPC following the narrow understanding advocated by the EBA (G 0001/04 and 0001/07) (Reasons, 3.2.4).

II. A possible way of assessing health risks is to use a risk matrix permitting to combine the levels of likelihood and health impact of a complication of a medical act with regard to a large number of patients, so as to obtain statistical health risk scores which may be used to decide what action should be taken. Such a risk assessment supports the view that an intravenous injection of a magnetic resonance contrast agent represents a minor routine intervention involving no substantial health risks when carried out with the required care and skill (Reasons, 3.2.5).

Schlagwörter
-
Orientierungssatz
-

ORDER

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is maintained as granted.